SWM
GILD icon

Sagace Wealth Management’s Gilead Sciences GILD Stock Holding History

Sagace Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,833
Closed -$225K – 74
2025
Q4 		$225K Buy
1,833
+6
+0.3% +$729 0.15% 65
2025
Q3 		$203K Buy
+1,827
New +$208K 0.14% 64

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sagace Wealth Management's GILD Position: Q1 2026 in Review

Sagace Wealth Management sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 1,833 shares — an estimated $225K sold.

Sagace Wealth Management first reported a position in GILD in Q3 2025 and held it in 2 quarters. The position peaked at $225K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Sagace Wealth Management reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Sagace Wealth Management sold 1,833 Gilead Sciences shares in Q1 2026, an estimated $225K.
  • Sagace Wealth Management first reported a position in Gilead Sciences in Q3 2025 and held it in 2 quarters.
  • Sagace Wealth Management's Gilead Sciences position peaked at $225K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Sagace Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.